FBR


FBR Reiterates Upbeat View Of Plug Power Inc (PLUG) Following Investor Meetings

In a research report released Friday, FBR analyst Carter Driscoll reiterated coverage on Plug Power Inc (NASDAQ:PLUG), with an Outperform rating and a …

FBR Bullish on Plug Power Inc (PLUG) Following Meeting with Management

FBR analyst Carter Driscoll and his team have recently met with Plug Power Inc (NASDAQ:PLUG) after the hydrogen fuel cell maker announced its agreement with …

FBR Reiterates Bullish Stance On Aurinia Pharmaceuticals Inc (AUPH) Following Development Updates

In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) with a …

FBR Boosts Price Target For Aurinia Pharmaceuticals Inc (AUPH) As Balance Sheet Improves

FBR analyst Vernon Bernardino, one of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) biggest bulls, is out today with a research note on AUPH, after the drug …

FBR Reiterates Buy On Arena Pharmaceuticals, Inc. (ARNA) Following 4Q16 Update

In a research report published Wednesday, FBR analyst Rahul Jasuja reiterated an Outperform rating on shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) with a …

Aurinia Pharmaceuticals Inc (AUPH): A Hot Acquisition Target in 2017

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are surging 18% today following fourth-quarter and full year 2016 financial results released Thursday evening that have since …

Aurinia Pharmaceuticals Inc (AUPH) Shares Continue to Soar as Voclosporin Success Opens Partnership Possibilities

  Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares have been skyrocketing following the biotech firm’s major success with its Phase IIb trial evaluating voclosporin (VCS) …

Walt Disney Co (DIS) Eases FBR’s Fears Following $74 Million Upside in Parks

Yesterday evening, Walt Disney Co (NYSE:DIS) released its fiscal first quarter earnings of 2017 that was mixed between a revenue miss, but an …

FBR Envisions Bullish Forecast for Aurinia Pharmaceuticals Inc (AUPH) Under New CEO

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) announced on Monday that Richard Glickman would be taking on new roles as chairman and CEO of the firm …

FBR Downgrades Galena Biopharma Inc (GALE) Right as Stock Skyrockets 30%

This morning, the firm revealed an independent group of experts has judged its breast cancer combination treatment of NeuVax with chemotherapy drug trastuzumab in …